Endometrial Cancer Trial, Recruiting NCT07480902 Sponsor: Timser SAPI de CV Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT07480902
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are in good general health
  • People aged between 18 and 85 years old
  • People who have fasted for at least 6 hours but no more than 12 hours before the study
  • People who have not had sexual intercourse in the 24 hours before the study
  • People who are willing to sign a written consent form agreeing to take part

Who may not be able to join:

  • People who have had a partial or full surgical removal of the uterus (hysterectomy)
  • People who are pregnant or may be pregnant — a urine pregnancy test will be carried out, and if the result is positive, the trial site will not include that person and will refer them for pregnancy care
  • People who are currently receiving cancer treatment such as chemotherapy, radiation therapy, or brachytherapy
  • People who are currently on their period
  • People who have a confirmed diagnosis of HIV or hepatitis
  • People who have taken blood-thinning medications such as aspirin (acetylsalicylic acid) within 24 hours before the study

A person may also be removed from the study if they decline any of the study procedures, if the trial gynecologist finds that a hysterectomy has taken place, or if the biological samples collected are not sufficient for testing.


Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Leopoldo E Gatica-Galina, MD in OB/GY & Gynecol Oncol, Consultorio Médico TIMSER

Phone: +52-55-9057-1000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Timser SAPI de CV
Registry
ClinicalTrials.gov
Start date
3 February 2026
Est. completion
1 April 2026

Where this trial is recruiting

🇲🇽 Mexico

Primary endpoints

Liquid-based Cytology results (categorical); Molecular screening result (numeric); HPV test results (categorical); Colposcopy diagnosis (categorical); Histopathology diagnosis (cathegorical)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov